Proteobacteria:Actinobacteria Ratio: A Two-Phylum Snapshot of Gut Strain

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

This test measures the balance between Proteobacteria and Actinobacteria in your gut to detect microbial imbalance linked to inflammation and loss of beneficial bacteria. Knowing your ratio can help guide interventions that may reduce risk of gut inflammation, IBS/IBD flares, and metabolic or immune-related issues.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

The Proteobacteria-to-actinobacteria ratio: A two-phylum snapshot of gut strain

The proteobacteria:actinobacteria ratio test summarizes the balance between two large bacterial groups. Proteobacteria include many common gut residents that can expand under stress, while Actinobacteria include beneficial genera like Bifidobacterium that help ferment complex carbohydrates.

Why does this matter? Your gut microbes help digest food, shape immune responses, influence inflammation, and produce metabolites that support the intestinal barrier. They also interact with metabolism and the gut–brain axis. The ratio captures a pattern often seen when the microbiome is strained, such as after antibiotics or during highly processed, low‑fiber eating. Although microbiome science is evolving, higher diversity and stable proportions of beneficial groups remain hallmarks of a resilient gut community.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why this ratio is a useful summary

The proteobacteria:actinobacteria ratio connects lab data to everyday health questions. A relatively higher Proteobacteria signal can accompany dysbiosis, transient inflammation, or recent antimicrobial exposure, while a relatively lower Actinobacteria signal may indicate reduced Bifidobacterium support for carbohydrate fermentation and short‑chain fatty acid production. People notice these shifts in real life as changes in stool form, more gas after certain foods, or sensitivity during stressful weeks. The ratio can also help clarify how specific factors are affecting your gut, such as a course of antibiotics, a tight travel schedule with on‑the‑go meals, a new high‑protein regimen, or the appetite and motility changes seen with GLP‑1–based weight‑loss therapies.

Zooming out, the microbiome is a systems player. Patterns linked to higher Proteobacteria have been observed alongside inflammatory states and metabolic stress in research, though causation is not guaranteed and context is essential. Regular microbiome testing, including this ratio, helps you watch how nutrition, fiber intake, probiotic use, stress management, and sleep routines influence microbial diversity and barrier‑supporting metabolites over time. The aim is not perfection but pattern recognition that can guide preventive care and long‑term wellness decisions with your clinician.

Reading the ratio

Your results are typically reported as the relative abundances of microbial groups compared to a reference population, along with a calculated proteobacteria:actinobacteria ratio. In general, a balanced adult microbiome shows higher overall diversity, robust representation of beneficial Actinobacteria such as Bifidobacterium, and only modest Proteobacteria. Laboratories may provide reference intervals or percentiles rather than a single “normal” number, because healthy microbiomes vary widely across populations, diets, and geographies.

When this ratio sits in a balanced pattern for you, it suggests efficient fiber fermentation, better short‑chain fatty acid output, lower inflammatory signaling, and a steadier gut barrier. If the ratio is elevated, it can indicate a microbiome under strain, with potential overrepresentation of Proteobacteria. If it is low due to depleted Actinobacteria, it can suggest reduced support from Bifidobacterium. These are functional clues, not diagnoses. They highlight areas to explore with your care team, especially if you have persistent gastrointestinal symptoms, metabolic changes, skin flares, or frequent infections.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

What a Proteobacteria:Actinobacteria ratio number really earns you

Context matters. Age, life stage, and recent events shape interpretation. For example, infant microbiomes naturally differ from adult patterns, and pregnancy involves immune and metabolic shifts that can influence results, so age‑appropriate references are important. Day‑to‑day variation, stool sampling differences, sequencing method, and reference database choice can all influence the readout. That is why this ratio is best viewed alongside other biomarkers like fecal calprotectin or metabolic labs and interpreted over time, paired with your history, diet, medications, and lifestyle. Used this way, the proteobacteria:actinobacteria ratio test helps translate complex microbiome signals into practical insight about digestion, energy, inflammation patterns, and long‑term gut resilience, while acknowledging that more research is still refining the details.

Frequently Asked Questions

References

  1. Shin NR, Whon TW, Bae JW (2015). Proteobacteria: Microbial signature of dysbiosis in gut microbiota. *Trends in Biotechnology*, *33*(9), 496-503. https://doi.org/10.1016/j.tibtech.2015.06.011
  2. Binda C, Lopetuso LR, Rizzatti G, Gibiino G, Cennamo V, Gasbarrini A (2018). Actinobacteria: A relevant minority for the maintenance of gut homeostasis. *Digestive and Liver Disease*, *50*(5), 421-428. https://doi.org/10.1016/j.dld.2018.02.012
  3. Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L (2016). Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut. *Frontiers in Microbiology*, *7*, 979. https://doi.org/10.3389/fmicb.2016.00979
  4. Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC (2019). What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. *Microorganisms*, *7*(1), 14. https://doi.org/10.3390/microorganisms7010014
  5. Allaband C, McDonald D, Vázquez-Baeza Y, Minich JJ, Tripathi A, Brenner DA, Loomba R, Smarr L, Sandborn WJ, Schnabl B, Dorrestein P, Zarrinpar A, Knight R (2019). Microbiome 101: Studying, analyzing, and interpreting gut microbiome data for clinicians. *Clinical Gastroenterology and Hepatology*, *17*(2), 218-230. https://doi.org/10.1016/j.cgh.2018.09.017

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey